Actinium Pharmaceuticals Statistics

Total Valuation

ATNM has a market cap or net worth of $37.75 million. The enterprise value is -$33.58 million.

Market Cap	37.75M
Enterprise Value	-33.58M

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025, after market close.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ATNM has 31.20 million shares outstanding. The number of shares has increased by 13.03% in one year.

Current Share Class	31.20M
Shares Outstanding	31.20M
Shares Change (YoY)	+13.03%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	0.51%
Owned by Institutions (%)	30.78%
Float	31.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.15
P/TBV Ratio	1.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.14, with a Debt / Equity ratio of 0.05.

Current Ratio	9.14
Quick Ratio	8.95
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -110.63% and return on invested capital (ROIC) is -72.30%.

Return on Equity (ROE)	-110.63%
Return on Assets (ROA)	-33.25%
Return on Invested Capital (ROIC)	-72.30%
Return on Capital Employed (ROCE)	-61.27%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.43% in the last 52 weeks. The beta is -0.27, so ATNM's price volatility has been lower than the market average.

Beta (5Y)	-0.27
52-Week Price Change	-84.43%
50-Day Moving Average	1.27
200-Day Moving Average	2.19
Relative Strength Index (RSI)	43.76
Average Volume (20 Days)	1,420,551

Short Selling Information

The latest short interest is 2.53 million, so 8.11% of the outstanding shares have been sold short.

Short Interest	2.53M
Short Previous Month	2.25M
Short % of Shares Out	8.11%
Short % of Float	8.15%
Short Ratio (days to cover)	2.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.12M
Pretax Income	-42.62M
Net Income	-38.24M
EBITDA	-41.91M
EBIT	-42.12M
Earnings Per Share (EPS)	-$1.27

Full Income Statement

Balance Sheet

The company has $72.90 million in cash and $1.57 million in debt, giving a net cash position of $71.33 million or $2.29 per share.

Cash & Cash Equivalents	72.90M
Total Debt	1.57M
Net Cash	71.33M
Net Cash Per Share	$2.29
Equity (Book Value)	32.76M
Book Value Per Share	1.05
Working Capital	66.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.07 million and capital expenditures -$11,000, giving a free cash flow of -$33.08 million.

Operating Cash Flow	-33.07M
Capital Expenditures	-11,000
Free Cash Flow	-33.08M
FCF Per Share	-$1.06

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.03%
Shareholder Yield	n/a
Earnings Yield	-101.31%
FCF Yield	-87.64%

Analyst Forecast

The average price target for ATNM is $8.75, which is 626.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.75
Price Target Difference	626.14%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.78%

Stock Forecasts

Stock Splits

The last stock split was on August 11, 2020. It was a reverse split with a ratio of 0.03333333:1.

Last Split Date	Aug 11, 2020
Split Type	Reverse
Split Ratio	0.03333333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1